FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elisabeth Seftor

Research Profile

Disorders

Anatomy

Physiology

Chemicals & Drugs

Living Beings

Procedures

Neoplasm Transplantation

Co-author Network

Publications

TOP 3
Thomas M Bodenstine; Zhila Khalkhali-Ellis; Philip A Pemberton; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Maspin: molecular mechanisms and therapeutic implications.
Richard E B Seftor; Katharine M Hardy; Angela R Hess; Dawn A Kirschmann; Naira V Margaryan; Elisabeth A Seftor; Mary J C Hendrix
Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.
Dawn A Kirschmann; Elisabeth A Seftor; Richard E B Seftor; Katharine M Hardy; Mary J C Hendrix
Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elisabeth Seftor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Thomas M Bodenstine; Zhila Khalkhali-Ellis; Philip A Pemberton; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Maspin: molecular mechanisms and therapeutic implications.
Cancer metastasis reviews 2012;31(3-4):529-51.
2012: Richard E B Seftor; Katharine M Hardy; Angela R Hess; Dawn A Kirschmann; Naira V Margaryan; Elisabeth A Seftor; Mary J C Hendrix
Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.
The American journal of pathology 2012;181(4):1115-25.
2012: Dawn A Kirschmann; Elisabeth A Seftor; Richard E B Seftor; Katharine M Hardy; Mary J C Hendrix
Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2726-32.
2012: Luigi Strizzi; E Aubrey Thompson; Cathy A Andorfer; Beiyun Chen; Xochiquetzal J Geiger; Katharine M Hardy; David W Hillman; Wilma L Lingle; Naira V Margaryan; Edith A Perez; Elisabeth A Seftor; Mary J C Hendrix
Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer.
Breast cancer research : BCR 2012;14(3):R75.
2012: Sergey Malchenko; Jose Morcuende; Tatiana Nikolskaya; Yuri Nikolsky; Stas Poyarkov; Elisabeth A Seftor; Marcelo B Soares; Hakim Abdulkawy; Maria de Fatima Bonaldo; Joseph Buckwalter; Thomas Casavant; Barry Deyoung; Susan L Hasegawa; Mary J C Hendrix; Raymond Hohl; Kemp Kernstine; Tamara Kucaba; Sean Kuo; Jeff W Stevens; Min Wang; Vera Maria F C Soares
Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.
Sarcoma 2012;2012():820254.
2011: Mitchell G Lawrence; Daniela Loessner; Naira V Margaryan; Lynne-Marie Postovit; Elisabeth A Seftor; Carson R Stephens; Megan Turner; Judith A Clements; Angus Collins; Kris M Kerr; John Lai; Mary J C Hendrix
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.
The Prostate 2011;71(11):1198-209.
2010: Katharine M Hardy; Dawn A Kirschmann; Elisabeth A Seftor; Naira V Margaryan; Lynne-Marie Postovit; Luigi Strizzi; Mary J C Hendrix
Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype.
Cancer research 2010;70(24):10340-50.
2010: Sergey Malchenko; Vasiliy Galat; Elisabeth A Seftor; Elio F Vanin; Fabricio F Costa; Richard E B Seftor; Marcelo B Soares; Mary J C Hendrix
Cancer hallmarks in induced pluripotent cells: new insights.
Journal of cellular physiology 2010;225(2):390-3.
2010: Christopher A Hamm; Jeff W Stevens; Hehuang Xie; Elio F Vanin; Jose A Morcuende; Hakeem Abdulkawy; Elisabeth A Seftor; Simone Treiger Sredni; Jared M Bischof; Deli Wang; Sergey Malchenko; Maria de Fatima Bonaldo; Thomas L Casavant; Mary J C Hendrix; Marcelo B Soares
Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors.
BMC cancer 2010;10():471.
2009: Luigi Strizzi; Katharine M Hardy; Elisabeth A Seftor; Fabricio F Costa; Dawn A Kirschmann; Richard E B Seftor; Lynne-Marie Postovit; Mary J C Hendrix
Development and cancer: at the crossroads of Nodal and Notch signaling.
Cancer research 2009;69(18):7131-4.
2009: Naira V Margaryan; M Sambasiva Rao; Elisabeth A Seftor; Luigi Strizzi; Daniel E Abbott; Mary J C Hendrix; Angela R Hess
EphA2 as a promoter of melanoma tumorigenicity.
Cancer biology & therapy 2009;8(3):279-88.
2009: Christopher A Hamm; Hehuang Xie; Fabricio F Costa; Elio F Vanin; Elisabeth A Seftor; Simone T Sredni; Jared Bischof; Deli Wang; Maria F Bonaldo; Mary J C Hendrix; Marcelo B Soares
Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity.
PloS one 2009;4(12):e8340.
2008: Daniel E Abbott; Caleb Bailey; Lynne-Marie Postovit; Elisabeth A Seftor; Naira V Margaryan; Richard E B Seftor; Mary J C Hendrix
The epigenetic influence of tumor and embryonic microenvironments: how different are they?
Cancer microenvironment : official journal of the International Cancer Microenvironment Society 2008;1(1):13-21.
2008: Jennifer C Kasemeier-Kulesa; Jessica M Teddy; Lynne-Marie Postovit; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix; Paul M Kulesa
Reprogramming multipotent tumor cells with the embryonic neural crest microenvironment.
Developmental dynamics : an official publication of the American Association of Anatomists 2008;237(10):2657-66.
2008: Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Mary J C Hendrix
Role of nodal signaling and the microenvironment underlying melanoma plasticity.
Pigment cell & melanoma research 2008;21(3):348-57.
2008: Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Dawn A Kirschmann; Alina Lipavsky; William W Wheaton; Daniel E Abbott; Richard E B Seftor; Mary J C Hendrix
Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(11):4329-34.
2008: Luigi Strizzi; Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Daniel E Abbott; Richard E B Seftor; David S Salomon; Mary J C Hendrix
Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.
Breast disease 2008;29():91-103.
2007: Angela R Hess; Naira V Margaryan; Elisabeth A Seftor; Mary J C Hendrix
Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors.
Developmental dynamics : an official publication of the American Association of Anatomists 2007;236(12):3283-96.
2007: Lynne-Marie Postovit; Fabricio F Costa; Jared M Bischof; Elisabeth A Seftor; Bo Wen; Richard E B Seftor; Andrew P Feinberg; M Bento Soares; Mary J C Hendrix
The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells.
Journal of cellular biochemistry 2007;101(4):908-17.
2007: Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; Jennifer C Kasemeier-Kulesa; Paul M Kulesa; Lynne-Marie Postovit
Reprogramming metastatic tumour cells with embryonic microenvironments.
Nature reviews. Cancer 2007;7(4):246-55.
2007: Lynne-Marie Postovit; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Targeting Nodal in malignant melanoma cells.
Expert opinion on therapeutic targets 2007;11(4):497-505.
2007: Daniel E Abbott; Lynne-Marie Postovit; Elisabeth A Seftor; Naira V Margaryan; Richard E B Seftor; Mary J C Hendrix
Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets.
Stem cell reviews 2007;3(1):68-78.
2006: Caleb Bailey; Zhila Khalkhali-Ellis; Elisabeth A Seftor; Mary J C Hendrix
Biological functions of maspin.
Journal of cellular physiology 2006;209(3):617-24.
2006: José D Rojas; Souad R Sennoune; Debasish Maiti; Karina Bakunts; M Reuveni; S C Sanka; Gloria M Martinez; Elisabeth A Seftor; Cynthia J Meininger; Guoyao Wu; Donald E Wesson; Mary J C Hendrix; Raul Martinez-Zaguilan
Vacuolar-type H+-ATPases at the plasma membrane regulate pH and cell migration in microvascular endothelial cells.
American journal of physiology. Heart and circulatory physiology 2006;291(3):H1147-57.
2006: Lynne-Marie Postovit; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Influence of the microenvironment on melanoma cell fate determination and phenotype.
Cancer research 2006;66(16):7833-6.
2006: Laura E Norwood; Timothy J Moss; Naira V Margaryan; Sara L Cook; Lindsay Wright; Elisabeth A Seftor; Mary J C Hendrix; Dawn A Kirschmann; Lori L Wallrath
A requirement for dimerization of HP1Hsalpha in suppression of breast cancer invasion.
The Journal of biological chemistry 2006;281(27):18668-76.
2006: Paul M Kulesa; Jennifer C Kasemeier-Kulesa; Jessica M Teddy; Naira V Margaryan; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(10):3752-7.
2006: Lynne-Marie Postovit; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells.
Stem cells (Dayton, Ohio) 2006;24(3):501-5.
2006: Angela R Hess; Elisabeth A Seftor; Lynn M Gruman; Michael S Kinch; Richard E B Seftor; Mary J C Hendrix
VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
Cancer biology & therapy 2006;5(2):228-33.
2006: Elisabeth A Seftor; Paul S Meltzer; Dawn A Kirschmann; Naira V Margaryan; Richard E B Seftor; Mary J C Hendrix
The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment.
Journal of cellular and molecular medicine 2006;10(1):174-96.
2005: Stacey L Payne; Ben Fogelgren; Angela R Hess; Elisabeth A Seftor; Elizabeth Louise Wiley; Sheri F T Fong; Katalin Csiszar; Mary J C Hendrix; Dawn A Kirschmann
Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Cancer research 2005;65(24):11429-36.
2005: Elisabeth A Seftor; Kevin Brown; Lynda Chin; Dawn A Kirschmann; William W Wheaton; Alexei Protopopov; Bin Feng; yoganand balagurunathan; Jeffrey M. Trent; Brian J Nickoloff; Richard E B Seftor; Mary J C Hendrix
Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
Cancer research 2005;65(22):10164-9.
2005: Angela R Hess; Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Galen B Schneider; Richard E B Seftor; Brian J Nickoloff; Mary J C Hendrix
Focal adhesion kinase promotes the aggressive melanoma phenotype.
Cancer research 2005;65(21):9851-60.
2005: Lisa Lee; Elisabeth A Seftor; Gregory Bonde; Robert A Cornell; Mary J C Hendrix
The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation.
Developmental dynamics : an official publication of the American Association of Anatomists 2005;233(4):1560-70.
2004: José D Rojas; Souad R Sennoune; Gloria M Martinez; Karina Bakunts; Cynthia J Meininger; Guoyao Wu; Donald E Wesson; Elisabeth A Seftor; Mary J C Hendrix; Raul Martinez-Zaguilan
Plasmalemmal vacuolar H+-ATPase is decreased in microvascular endothelial cells from a diabetic model.
Journal of cellular physiology 2004;201(2):190-200.
2004: Daisy W J van der Schaft; Richard E B Seftor; Elisabeth A Seftor; Angela R Hess; Lynn M Gruman; Dawn A Kirschmann; Yumi Yokoyama; Arjan W Griffioen; Mary J C Hendrix
Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells.
Journal of the National Cancer Institute 2004;96(19):1473-7.
2004: Jian-Zhong Qin; Lawrence S Stennett; Patricia Bacon; Barbara Bodner; Mary J C Hendrix; Richard E B Seftor; Elisabeth A Seftor; Naira V Margaryan; Pam Pollock; Amy Curtis; Jeffrey M. Trent; Frank Bennett; Lucio Miele; Brian J Nickoloff
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas.
Molecular cancer therapeutics 2004;3(8):895-902.
2004: Anil K Sood; Mavis S Fletcher; Jeremy E Coffin; Maria Yang; Elisabeth A Seftor; Lynn M Gruman; David M Gershenson; Mary J C Hendrix
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
American journal of obstetrics and gynecology 2004;190(4):899-909.
2004: Jirapat Chunthapong; Elisabeth A Seftor; Zhila Khalkhali-Ellis; Richard E B Seftor; Sumaira Amir; David M Lubaroff; Paul M Heidger; Mary J C Hendrix
Dual roles of E-cadherin in prostate cancer invasion.
Journal of cellular biochemistry 2004;91(4):649-61.
2003: Wolfram Ruf; Elisabeth A Seftor; Ramona J Petrovan; Robert M Weiss; Lynn M Gruman; Naira V Margaryan; Richard E B Seftor; Yohei Miyagi; Mary J C Hendrix
Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
Cancer research 2003;63(17):5381-9.
2003: Angela R Hess; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
Cancer research 2003;63(16):4757-62.
2003: Valerie A Odero-Marah; Zhila Khalkhali-Ellis; Jirapat Chunthapong; Sumaira Amir; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.
Cancer biology & therapy 2003;2(4):398-403.
2003: Mary J C Hendrix; Elisabeth A Seftor; Angela R Hess; Richard E B Seftor
Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
Nature reviews. Cancer 2003;3(6):411-21.
2003: Mary J C Hendrix; Elisabeth A Seftor; Angela R Hess; Richard E B Seftor
Molecular plasticity of human melanoma cells.
Oncogene 2003;22(20):3070-5.
2003: Mary J C Hendrix; Elisabeth A Seftor; Dawn A Kirschmann; Vito Quaranta; Richard E B Seftor
Remodeling of the microenvironment by aggressive melanoma tumor cells.
Annals of the New York Academy of Sciences 2003;995():151-61.
2002: Anil K Sood; Mavis S Fletcher; Christopher M Zahn; Lynn M Gruman; Jeremy E Coffin; Elisabeth A Seftor; Mary J C Hendrix
The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.
Cancer biology & therapy 2002;1(6):661-4.
2002: Richard E B Seftor; Elisabeth A Seftor; Dawn A Kirschmann; Mary J C Hendrix
Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.
Molecular cancer therapeutics 2002;1(13):1173-9.
2002: Elisabeth A Seftor; Paul S Meltzer; Gina C Schatteman; Lynn M Gruman; Angela R Hess; Dawn A Kirschmann; Richard E B Seftor; Mary J C Hendrix
Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry.
Critical reviews in oncology/hematology 2002;44(1):17-27.
2002: Anil K Sood; Mavis S Fletcher; Lynn M Gruman; Jeremy E Coffin; Sarvenaz Jabbari; Zhila Khalkhali-Ellis; Nancy Arbour; Elisabeth A Seftor; Mary J C Hendrix
The paradoxical expression of maspin in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2924-32.
2002: Dawn A Kirschmann; Elisabeth A Seftor; Sheri F T Fong; Daniel R C Nieva; Colleen M Sullivan; Elijah M Edwards; Pascal Sommer; Katalin Csiszar; Mary J C Hendrix
A molecular role for lysyl oxidase in breast cancer invasion.
Cancer research 2002;62(15):4478-83.
2002: Valerie A Odero-Marah; Zhila Khalkhali-Ellis; Galen B Schneider; Elisabeth A Seftor; Richard E B Seftor; John G Koland; Mary J C Hendrix
Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells.
Biochemical and biophysical research communications 2002;295(4):800-5.
2002: Anuja Dokras; L M G Gardner; Dawn A Kirschmann; Elisabeth A Seftor; Mary J C Hendrix
The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development.
Placenta 2002;23(4):274-80.
2002: Navesh Sharma; Richard E B Seftor; Elisabeth A Seftor; Lynn M Gruman; Paul M Heidger; Michael B Cohen; David M Lubaroff; Mary J C Hendrix
Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry.
The Prostate 2002;50(3):189-201.
2002: Mary J C Hendrix; Richard E B Seftor; Elisabeth A Seftor; Lynn M Gruman; Lisa Lee; Brian J Nickoloff; Lucio Miele; Don D Sheriff; Gina C Schatteman
Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination.
Cancer research 2002;62(3):665-8.
2002: Elisabeth A Seftor; Paul S Meltzer; Dawn A Kirschmann; Jacob Pe'er; Andrew J Maniotis; Jeffrey M. Trent; Robert Folberg; Mary J C Hendrix
Molecular determinants of human uveal melanoma invasion and metastasis.
Clinical & experimental metastasis 2002;19(3):233-46.
2001: Anuja Dokras; L M G Gardner; Elisabeth A Seftor; Mary J C Hendrix
Regulation of human cytotrophoblast morphogenesis by hepatocyte growth factor/scatter factor.
Biology of reproduction 2001;65(4):1278-88.
2001: Richard E B Seftor; Elisabeth A Seftor; N Koshikawa; Paul S Meltzer; L M G Gardner; Martin Bilban; William Stetler-Stevenson; Vito Quaranta; Mary J C Hendrix
Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
Cancer research 2001;61(17):6322-7.
2001: Mary J C Hendrix; Elisabeth A Seftor; Paul S Meltzer; L M G Gardner; Angela R Hess; Dawn A Kirschmann; Gina C Schatteman; Richard E B Seftor
Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(14):8018-23.
2001: Nancy B Ray; Daniel R C Nieva; Elisabeth A Seftor; Zhila Khalkhali-Ellis; Stanley J Naides
Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts.
Arthritis and rheumatism 2001;44(7):1582-6.
2001: Angela R Hess; Elisabeth A Seftor; L M G Gardner; Kelly L Carles-Kinch; Galen B Schneider; Richard E B Seftor; Michael S Kinch; Mary J C Hendrix
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Cancer research 2001;61(8):3250-5.
2001: Anil K Sood; Elisabeth A Seftor; Mavis S Fletcher; L M G Gardner; Paul M Heidger; R E Buller; Richard E B Seftor; Mary J C Hendrix
Molecular determinants of ovarian cancer plasticity.
The American journal of pathology 2001;158(4):1279-88.
2001: Wei Zheng; Elisabeth A Seftor; Cynthia J Meininger; Mary J C Hendrix; Robert J Tomanek
Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta.
American journal of physiology. Heart and circulatory physiology 2001;280(2):H909-17.
2000: Zhila Khalkhali-Ellis; Elisabeth A Seftor; Daniel R C Nieva; Robert J Handa; richard price; Dawn A Kirschmann; V M Baragi; Ram V Sharma; Ramesh C Bhalla; Terry L Moore; Mary J C Hendrix
Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis.
The Journal of rheumatology 2000;27(7):1622-31.
2000: Dawn A Kirschmann; Ruth A Lininger; L M G Gardner; Elisabeth A Seftor; Valerie A Odero-Marah; A M Ainsztein; W C Earnshaw; Lori L Wallrath; Mary J C Hendrix
Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer.
Cancer research 2000;60(13):3359-63.
2000: Mary J C Hendrix; Elisabeth A Seftor; Dawn A Kirschmann; Richard E B Seftor
Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.
Breast cancer research : BCR 2000;2(6):417-22.
1999: P A Thomas; Dawn A Kirschmann; J R Cerhan; Robert Folberg; Elisabeth A Seftor; T A Sellers; Mary J C Hendrix
Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2698-703.
1999: E W Lam; Ralf Michael Zwacka; Elisabeth A Seftor; Daniel R C Nieva; B L Davidson; J F Engelhardt; Mary J C Hendrix; Larry W Oberley
Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells.
Free radical biology & medicine 1999;27(5-6):572-9.
1999: Andrew J Maniotis; Robert Folberg; A Hess; Elisabeth A Seftor; L M G Gardner; Jacob Pe'er; Jeffrey M. Trent; Paul S Meltzer; Mary J C Hendrix
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
The American journal of pathology 1999;155(3):739-52.
1999: Dawn A Kirschmann; Elisabeth A Seftor; Daniel R C Nieva; E A Mariano; Mary J C Hendrix
Differentially expressed genes associated with the metastatic phenotype in breast cancer.
Breast cancer research and treatment 1999;55(2):127-36.
1999: Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Molecular role(s) for integrins in human melanoma invasion.
Cancer metastasis reviews 1999;18(3):359-75.
1998: Richard E B Seftor; Elisabeth A Seftor; Shijie Sheng; P A Pemberton; R Sager; Mary J C Hendrix
maspin suppresses the invasive phenotype of human breast carcinoma.
Cancer research 1998;58(24):5681-5.
1998: Elisabeth A Seftor; Richard E B Seftor; Daniel R C Nieva; Mary J C Hendrix
Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis.
Advances in dental research 1998;12(2):103-10.
1998: Richard E B Seftor; Elisabeth A Seftor; J E De Larco; D E Kleiner; J Leferson; William Stetler-Stevenson; T F McNamara; Lorne M Golub; Mary J C Hendrix
Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.
Clinical & experimental metastasis 1998;16(3):217-25.
1998: Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; Dawn A Kirschmann; L M G Gardner; H Culver Boldt; M Meyer; Jacob Pe'er; Robert Folberg
Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
The American journal of pathology 1998;152(4):855-63.
1998: Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; L M G Gardner; H Culver Boldt; M Meyer; Jacob Pe'er; Robert Folberg
Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Laboratory investigation; a journal of technical methods and pathology 1998;78(2):153-63.
1997: Zhila Khalkhali-Ellis; Elisabeth A Seftor; Daniel R C Nieva; Richard E B Seftor; H A Samaha; L Bultman; J E De Larco; Akgun Ince; Terry L Moore; Mary J C Hendrix
Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population.
The Journal of rheumatology 1997;24(12):2451-60.
1997: Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; K T Trevor
Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior.
The American journal of pathology 1997;150(2):483-95.
1996: Mary J C Hendrix; Elisabeth A Seftor; Y W Chu; K T Trevor; Richard E B Seftor
Role of intermediate filaments in migration, invasion and metastasis.
Cancer metastasis reviews 1996;15(4):507-25.
1996: Shijie Sheng; J Carey; Elisabeth A Seftor; L Dias; Mary J C Hendrix; Ruth Sager
Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11669-74.
1996: Raul Martinez-Zaguilan; Elisabeth A Seftor; Richard E B Seftor; Y W Chu; Robert J Gillies; Mary J C Hendrix
Acidic pH enhances the invasive behavior of human melanoma cells.
Clinical & experimental metastasis 1996;14(2):176-86.
1996: Y W Chu; Elisabeth A Seftor; Lewis H Romer; Mary J C Hendrix
Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility.
The American journal of pathology 1996;148(1):63-9.
1995: Ratna B Ray; Robert Steele; Elisabeth A Seftor; M Hendrix
Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice.
Cancer research 1995;55(17):3747-51.
1994: Z Zou; Anthony Anisowicz; Mary J C Hendrix; A Thor; M Neveu; Shijie Sheng; K Rafidi; Elisabeth A Seftor; Ruth Sager
Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.
Science (New York, N.Y.) 1994;263(5146):526-9.
1993: DA Bull; Elisabeth A Seftor; M J Hendrix; Douglas F Larson; Glenn C Hunter; C W Putnam
Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay.
The Journal of surgical research 1993;55(5):473-9.
1993: Richard E B Seftor; Elisabeth A Seftor; William Stetler-Stevenson; Mary J C Hendrix
The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion.
Cancer research 1993;53(14):3411-5.
1992: Richard E B Seftor; Elisabeth A Seftor; K R Gehlsen; William Stetler-Stevenson; P D Brown; E Ruoslahti; Mary J C Hendrix
Role of the alpha v beta 3 integrin in human melanoma cell invasion.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1557-61.
1992: Mary J C Hendrix; Elisabeth A Seftor; Y W Chu; Richard E B Seftor; Raymond B Nagle; K M McDaniel; S P Leong; K H Yohem; A M Leibovitz; Frank L Meyskens
Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential.
Journal of the National Cancer Institute 1992;84(3):165-74.
1992: Mary J C Hendrix; Elisabeth A Seftor; Thomas M Grogan; Richard E B Seftor; Evan M Hersh; E A Boyse; L A Liotta; W Stetler-Stevenson; C G Ray
Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice.
Molecular and cellular probes 1992;6(1):59-65.
1991: Richard E B Seftor; Elisabeth A Seftor; W J Grimes; L A Liotta; William Stetler-Stevenson; Danny R Welch; Mary J C Hendrix
Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression.
Melanoma research 1991;1(1):43-54.
1991: Danny R Welch; J E Bisi; B E Miller; D Conaway; Elisabeth A Seftor; K H Yohem; L B Gilmore; Richard E B Seftor; M Nakajima; Mary J C Hendrix
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line.
International journal of cancer. Journal international du cancer 1991;47(2):227-37.
1990: Elisabeth A Seftor; Richard E B Seftor; M J Hendrix
Selection of invasive and metastatic subpopulations from a heterogeneous human melanoma cell line.
BioTechniques 1990;9(3):324-31.
1990: Mary J C Hendrix; Elisabeth A Seftor; M D Eckes; A L Winters; S P Leong; P Scuderi
Effect of interferon-gamma on the expression of HLA-DR by human melanoma cells of varying metastatic potential.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1990;3(3):162-7.
1990: Linda C Meade-Tollin; B L Pipes; S J Anderson; Elisabeth A Seftor; Mary J C Hendrix
A comparison of levels of intrinsic single strand breaks/alkali labile sites associated with human melanoma cell invasion.
Cancer letters 1990;53(1):45-54.
1990: Mary J C Hendrix; W R Wood; Elisabeth A Seftor; Dafna Lotan; M Nakajima; R L Misiorowski; Richard E B Seftor; W G Stetler-Stevenson; S J Bevacqua; L A Liotta
Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor.
Cancer research 1990;50(13):4121-30.
1990: W R Wood; Elisabeth A Seftor; Dafna Lotan; M Nakajima; R L Misiorowski; Richard E B Seftor; Reuben Lotan; Mary J C Hendrix
Retinoic acid inhibits human melanoma tumor cell invasion.
Anticancer research 1990;10(2A):423-32.
1990: Richard E B Seftor; Elisabeth A Seftor; A E Cress; Mary J C Hendrix
Profiles of human melanoma cell surface proteins: effects of culturing on two different substrates.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1990;3(1):44-8.
1989: K H Yohem; Elisabeth A Seftor; Frank L Meyskens; Mary J C Hendrix
Cloning efficiency of human melanoma cells is modulated after invasion through a reconstituted basement membrane.
Cancer letters 1989;45(2):135-43.
1989: Danny R Welch; T J Lobl; Elisabeth A Seftor; P J Wack; P A Aeed; K H Yohem; Richard E B Seftor; Mary J C Hendrix
Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents.
International journal of cancer. Journal international du cancer 1989;43(3):449-57.
1989: Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; R L Misiorowski; P Z Saba; P Sundareshan; Danny R Welch
Comparison of tumor cell invasion assays: human amnion versus reconstituted basement membrane barriers.
Invasion & metastasis 1989;9(5):278-97.
1987: Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; I J Fidler
A simple quantitative assay for studying the invasive potential of high and low human metastatic variants.
Cancer letters 1987;38(1-2):137-47.